GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (OTCPK:FSNUY) » Definitions » COGS-to-Revenue

Fresenius SE KGaA (Fresenius SE KGaA) COGS-to-Revenue : 0.77 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Fresenius SE KGaA COGS-to-Revenue?

Fresenius SE KGaA's Cost of Goods Sold for the three months ended in Dec. 2023 was $4,778 Mil. Its Revenue for the three months ended in Dec. 2023 was $6,192 Mil.

Fresenius SE KGaA's COGS to Revenue for the three months ended in Dec. 2023 was 0.77.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Fresenius SE KGaA's Gross Margin % for the three months ended in Dec. 2023 was 22.84%.


Fresenius SE KGaA COGS-to-Revenue Historical Data

The historical data trend for Fresenius SE KGaA's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA COGS-to-Revenue Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 0.72 0.73 0.75 0.77

Fresenius SE KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.75 0.77 0.77 0.77

Fresenius SE KGaA COGS-to-Revenue Calculation

Fresenius SE KGaA's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=18801.527 / 24317.339
=0.77

Fresenius SE KGaA's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=4777.535 / 6191.93
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius SE KGaA  (OTCPK:FSNUY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Fresenius SE KGaA's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 4777.535 / 6191.93
=22.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Fresenius SE KGaA COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA (Fresenius SE KGaA) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Fresenius SE KGaA (Fresenius SE KGaA) Headlines

From GuruFocus

Tweedy Browne Fund's 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood 05-04-2021

Tweedy Browne Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood 06-01-2021

Top 1st-Quarter Trades of the Tweedy Browne Global Value Fund

By Margaret Moran Margaret Moran 04-13-2021

Tweedy Brown Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood 05-04-2021